https://www.selleckchem.com/pr....oducts/BafilomycinA1
Clozapine remains the most effective intervention for treatment resistant schizophrenia; however, its use is prohibited following neutropenias. We review neutrophil biology as applied to clozapine and describe the strategies to initiate clozapine following neutropenia used in a case series of 14 consecutive patients rechallenged in a United Kingdom (UK) high-secure psychiatric hospital. We examine outcomes including the use of seclusion and transfer. A case series of 14 male patients with treatment resistant schizophrenia treated
Like
Comment
Share
